The company's humanized transgenic antibody discovery technology provides broad, non-exclusive access to drug discovery tools, enabling scientists to efficiently work on their antibody projects. Alloy Therapeutics empowers the global scientific community to make better medicines together by providing affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma.